A major breakthrough in cancer research is emerging with the use of mini-antibodies to re-engage mutated p53. This essential cancer protector protein is frequently inactivated in several kinds of tumors, leading https://socialioapp.com/story6837464/vhh-fragments-reactivate-tumor-suppressor-p53-the-potential-pathway-for-cancer-treatment